Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial

EuroIntervention 2011;6:687-694.

Marcus Wiemer1, MD; Andreas König2, MD; Johannes Rieber2, MD; Hae-Young Sohn2, MD; Marcus Leibig2, MD; Karl Theisen2, MD; Volker Klauss2, MD; Christoph Langer1, MD; Oliver Lindner3, MD; Dieter Horstkotte1, MD, FESC, FACCP; Thomas M. Schiele2*, MD, FESC, FSCAI

1. Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Bad Oeynhausen, Germany; 2. Cardiology Division, Hospital of the Ludwig-Maximilians-University of Munich, Munich, Germany; 3. Department of Nuclear Medicine, Heart and Diabetes

Aims: Recent trials with different designs indicated that drug-eluting stents may be superior to vascular brachytherapy (VBT) for the treatment of in-stent restenosis (ISR). We performed a

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

coronary artery diseasebrachytherapydrug eluting stentsirolimus eluting stentivus

Share on Facebook Share on Twitter Share on Linkedin

Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial

Read next article

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke